{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-24-000105","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.384815+00:00","generated_at":"2026-05-30T06:44:36.219568+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integra LifeSciences names Mojdeh Poul as President & CEO effective Jan 6, 2025","bullets":["Mojdeh Poul appointed President & CEO, effective January 6, 2025, succeeding Jan De Witte.","Poul previously EVP & Group President of 3M's $8.5B global healthcare business.","Poul to receive base salary of $1.05M, target bonus 125%, and initial equity awards totaling $6.75M.","Jan De Witte's resignation is part of a previously announced succession plan; no disagreement.","Stuart Essig to remain Executive Chairman temporarily before returning to non-executive role."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-24-000105","json":"https://secwatch.observer/filing/0000917520-24-000105.json","markdown":"https://secwatch.observer/filing/0000917520-24-000105.md","text":"https://secwatch.observer/filing/0000917520-24-000105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/0000917520-24-000105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/iart-20241104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:44:36.219568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"62df175704","claim":"Mojdeh Poul was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On November 4, 2024, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Mojdeh Poul to serve as its President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/0000917520-24-000105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}